MAPT and Alzheimer disease: PICALM was found to associate with both 3R and 4R tau inclusions in AD and primary tauopathies, and soluble PICALM levels were inversely correlated with phosphotau,47 suggesting a biological link between this protein involved in clathrin‐mediated endocytosis and tau.